AAOpt 2025: New data demonstrate patient preference of Acuvue Oasys Max 1-Day for Astigmatism for vision, comfort

Giovanna Olivares, OD, detailed her 2 poster presentations, “Patient reported vision outcomes for 2 daily disposable toric soft contact lenses” and “Evaluation of treatment effects in a study comparing 2 daily disposable toric soft contact lenses,” during the American Academy of Optometry's (AAOpt) Academy 2025 meeting in Boston, Massachusetts. The data she presented demonstrates that Acuvue Oasys Max 1-Day for Astigmatism (Johnson & Johnson) contact lenses that demonstrated higher end-of-day comfort when compared to Dailies Total1 for Astigmatism. Additionally, when the Oasys lens was worn after the dailies, positive feedback of overall opinion increased to 80% compared to 33.3% when the dailies were worn after the Oasys lens.

Transcript

This transcript has been edited lightly for clarity and length.

Giovanna Olivares, OD:

I'm Dr. Giovanna Olivares, Global Director, R&D for mature eye and astigmatism, for Johnson & Johnson Vision. We're now the first and only family of daily disposable contact lenses that offers the MAX family, to young people, young people with astigmatism, older persons, and older persons with astigmatism. So nearly anybody that walks in the office can have the MAX technology.

I think it's the combination of the three technologies that we have in the OASYS MAX for astigmatism. The OptiBlue technology, that filters the blue violet [light] that may be coming off the screen. We have a TearStable technology that provides better tear stability. When you're on a computer screen, your tears will break up more, because we don't blink as much. So therefore, when we're in the computer screens, we we don't see as well, and we're not comfortable. The TearStable technology has proven to have two times less evaporation, as compared to other brands, and it also has shown to have a longer tear breakup time. Combination of that, and the Blink Stabilized design, is what really creates the experience for the patient.

Over the next decades, I think, you know, obviously, this contact lens offers a light-filtering technology as well as a tear stabilizing technology. I think as we're going into the future, we're going to see that our patients are going to be using their eyes even in more advanced or more challenging environments. Things like the tear stable and the OptiBlue are going to help them now, but we're seeing that in the future, that's the way that we're going to have to deliver better products for our patients.